Google
ONCO 株価分析 — Onconetix Inc (Healthcare >> Biotechnology)
ONCO に関するよくある質問
ONCOのPER（株価収益率）は？
Onconetix Inc（ONCO）は現在PER 0.51倍で取引されています。
ONCOのROE（自己資本利益率）は？
Onconetix IncのROEは-82.59%です。
ONCOの配当利回りは？
Onconetix Incの配当利回りは0.00%です。
ONCOの品質スコア（Quality Score）は？
当社のAIはONCOの総合財務品質を100点中31点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
ONCOは今が買い時ですか？
当社AIのタイミングスコアは100点中27点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
ONCOはどのセクターに属しますか？
Onconetix IncはHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）
ONCO AI Analysis Summary
Our AI summary for ONCO: Onconetix Inc (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.51, ROE of -82.59%, a dividend yield of 0.00%. Its financial Quality Score stands at 31/100 — fundamentals below the market average. The AI Timing Score is 27/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 0.83
Price
-0.02
(-1.89%)
Day Change
|
|
|---|
ONCO, ファンダメンタルスコアはnot good ( ファンダメンタル = 31) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
ROEの伸びが低い
平均ROEが低い
ROAがROEに比べて低い
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Deepscope 分析 |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 91 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 0.83 |
| PBV / Sector |
0.25 / 5.20
GREAT
|
| Earning Per Share | -2.76 |
| PE / Sector |
0.51 / 19.97
GREAT
|
| PEG or PE/Growth / Sector |
-0.02 / 1.22
|
| Average 1M Daily Value |
0.28 M
GREAT
|
| Average 1W Daily Value |
0.18 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
41% |
| ポイントになる統計 |
|
47% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-01 08:00:16 |
| Symbol | ONCO |
| Name | ONCONETIX INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 3.69 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 2.90 / 9,903.94 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 201 East Fifth Street, Cincinnati, OH, United States, 45202
Phone: 513 620 4101
Website: https://www.onconetix.com
Sector: Healthcare >> Biotechnology
Description: Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products; and with Immunovia AB for the development, manufacturing, and commercialization of the PancreaSure test. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was founded in 2018 and is headquartered in Cincinnati, Ohio.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
